Status:
NOT_YET_RECRUITING
Sleep Disturbances and Their Association With Serum Magnesium Level in Patients With Major Depressive Disorder
Lead Sponsor:
Assiut University
Conditions:
Depressive Disorder
Sleep Disturbances
Eligibility:
All Genders
18+ years
Brief Summary
This cross-sectional study investigates the relationship between serum magnesium levels and the presence of sleep disturbances among patients with major depressive disorder (MDD).
Detailed Description
Major depressive disorder is a highly prevalent psychiatric condition often accompanied by disabling sleep disturbances, including insomnia and hypersomnia. Evidence suggests that magnesium, a vital t...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of major depressive disorder
- age 18 years and older
- Ability to complete questionnaires (BDI-II and PSQI; validated Arabic versions)
- Willing to participate and provide informed consent
Exclusion
- hronic renal failure or metabolic disorders affecting magnesium balance
- Current use of medications known to significantly interfere with serum magnesium (e.g., long-term diuretics, proton pump inhibitors) unless stable and documented
- Presence of other comorbid psychiatric disorders
- Cognitive impairment or language difficulties preventing questionnaire completion
Key Trial Info
Start Date :
August 30 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07198477
Start Date
August 30 2026
End Date
December 30 2027
Last Update
September 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.